Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust

AIMS: The SARS‐CoV‐2 virus binds to the angiotensin‐converting enzyme 2 (ACE2) receptor for cell entry. It has been suggested that angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB), which are commonly used in patients with hypertension or diabetes and may rai...

Descripción completa

Detalles Bibliográficos
Autores principales: Bean, Daniel M., Kraljevic, Zeljko, Searle, Thomas, Bendayan, Rebecca, Kevin, O'Gallagher, Pickles, Andrew, Folarin, Amos, Roguski, Lukasz, Noor, Kawsar, Shek, Anthony, Zakeri, Rosita, Shah, Ajay M., Teo, James T.H., Dobson, Richard J.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2020
Materias:
COVID‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301045/
https://www.ncbi.nlm.nih.gov/pubmed/32485082
http://dx.doi.org/10.1002/ejhf.1924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301045/
https://www.ncbi.nlm.nih.gov/pubmed/32485082
http://dx.doi.org/10.1002/ejhf.1924

Ejemplares similares